Detalhe da pesquisa
1.
White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-Tuscany Study.
Int J Geriatr Psychiatry
; 31(6): 611-8, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26489377
2.
Operationalizing mild cognitive impairment criteria in small vessel disease: the VMCI-Tuscany Study.
Alzheimers Dement
; 12(4): 407-18, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26079418
3.
White matter microstructural damage in small vessel disease is associated with Montreal cognitive assessment but not with mini mental state examination performances: vascular mild cognitive impairment Tuscany study.
Stroke
; 46(1): 262-4, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25395414
4.
The VAS-COG clinic: an out-patient service for patients with cognitive and behavioral consequences of cerebrovascular diseases.
Neurol Sci
; 33(6): 1277-83, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22258361
5.
Longitudinal changes in MoCA performances in patients with mild cognitive impairment and small vessel disease. Results from the VMCI-Tuscany Study.
Cereb Circ Cogn Behav
; 2: 100008, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-36324712
6.
Familial cerebral cavernous malformation: report of a further Italian family.
Neurol Sci
; 30(2): 143-7, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19184323
7.
Generation of multiparametric MRI maps by using Gd-labelled- RBCs reveals phenotypes and stages of murine prostate cancer.
Sci Rep
; 8(1): 10567, 2018 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30002426
8.
Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients.
Dement Geriatr Cogn Dis Extra
; 8(1): 104-116, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29706987
9.
Resveratrol has anti-thyroid effects both in vitro and in vivo.
Food Chem Toxicol
; 107(Pt A): 237-247, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28668442
10.
Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds.
Oncotarget
; 7(37): 58743-58758, 2016 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27542212
11.
Cerebral microbleeds in patients with mild cognitive impairment and small vessel disease: The Vascular Mild Cognitive Impairment (VMCI)-Tuscany study.
J Neurol Sci
; 368: 195-202, 2016 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27538632
12.
The Florence VAS-COG clinic: a model for the care of patients with cognitive and behavioral disturbances consequent to cerebrovascular diseases.
J Alzheimers Dis
; 42 Suppl 4: S453-61, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25114087
13.
Risk and Determinants of Dementia in Patients with Mild Cognitive Impairment and Brain Subcortical Vascular Changes: A Study of Clinical, Neuroimaging, and Biological Markers-The VMCI-Tuscany Study: Rationale, Design, and Methodology.
Int J Alzheimers Dis
; 2012: 608013, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22550606
14.
Stroke recurrence in an elderly CADASIL patient on aspirin discontinuation due to severe auto-immune thrombocytopenia.
Aging Clin Exp Res
; 22(1): 98-9, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20305371